BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 21311378)

  • 1. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.
    Musahl C; Henkes H; Vajda Z; Coburger J; Hopf N
    Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.
    Duman E; Karakoç F; Pinar HU; Dogan R; Fırat A; Yıldırım E
    Interv Neuroradiol; 2017 Dec; 23(6):636-643. PubMed ID: 28956512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study.
    Dehdashti AR; Binaghi S; Uske A; Regli L
    Neurol India; 2011; 59(6):810-6. PubMed ID: 22234190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage.
    Kerz T; Boor S; Beyer C; Welschehold S; Schuessler A; Oertel J
    Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion.
    Doukas A; Petridis AK; Barth H; Jansen O; Maslehaty H; Mehdorn HM
    Acta Neurochir Suppl; 2011; 112():93-6. PubMed ID: 21691994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Hockel K; Diedler J; Steiner J; Birkenhauer U; Danz S; Ernemann U; Schuhmann MU
    World Neurosurg; 2016 Apr; 88():104-112. PubMed ID: 26732964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
    Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU
    World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
    Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
    Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
    von der Brelie C; Doukas A; Stopfer A; Larsen N; Mehdorn M; Synowitz M; Jansen O
    World Neurosurg; 2017 Apr; 100():504-513. PubMed ID: 28131927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
    Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB
    Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm.
    Mayer TE; Dichgans M; Straube A; Birnbaum T; Müller-Schunk S; Hamann GF; Schulte-Altedorneburg G
    Cardiovasc Intervent Radiol; 2008; 31(6):1200-4. PubMed ID: 18446409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage.
    Kieninger M; Flessa J; Lindenberg N; Bele S; Redel A; Schneiker A; Schuierer G; Wendl C; Graf B; Silbereisen V
    Neurocrit Care; 2018 Feb; 28(1):65-76. PubMed ID: 28685393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation.
    Paľa A; Schneider M; Brand C; Pedro MT; Özpeynirci Y; Schmitz B; Wirtz CR; Kapapa T; König R; Braun M
    Neurosurg Rev; 2019 Jun; 42(2):463-469. PubMed ID: 29804157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intra-arterial infusion of nimodipine at the onset of resistant vasospasm in aneurysmal subarachnoidal haemorrhage. Technical report.
    Doukas A; Petridis AK; Barth H; Jansen O; Mehdorn HM
    Neurol Res; 2011 Apr; 33(3):290-4. PubMed ID: 20626962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone.
    Schmidt U; Bittner E; Pivi S; Marota JJ
    Anesth Analg; 2010 Mar; 110(3):895-902. PubMed ID: 20185665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion.
    Hänggi D; Turowski B; Beseoglu K; Yong M; Steiger HJ
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1053-60. PubMed ID: 18372422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.